• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
MIKA Pharma GmbH - Product Pipeline Review - Q4 2010 Product Image

MIKA Pharma GmbH - Product Pipeline Review - Q4 2010

  • ID: 1446473
  • November 2010
  • 27 pages
  • GlobalData

MIKA Pharma GmbH – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “MIKA Pharma GmbH - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- MIKA Pharma GmbH - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of MIKA Pharma GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across READ MORE >

Note: Product cover images may vary from those shown



List of Tables
List of Figures
MIKA Pharma GmbH Snapshot
MIKA Pharma GmbH Overview
Key Information
Key Facts
MIKA Pharma GmbH – Research and Development Overview
Key Therapeutic Areas
MIKA Pharma GmbH – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
MIKA Pharma GmbH – Pipeline Products Glance
MIKA Pharma GmbH – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
MIKA Pharma GmbH Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
MIKA Pharma GmbH – Drug Profiles
MK03
Product Description
Mechanism of Action
R&D Progress
MK22
Product Description
Mechanism of Action
R&D Progress
MK51
Product Description
Mechanism of Action
R&D Progress
MK52
Product Description
Mechanism of Action
R&D Progress
MK49
Product Description
Mechanism of Action
R&D Progress
MK50
Product Description
Mechanism of Action
R&D Progress
MIKA Pharma GmbH – Pipeline Analysis
MIKA Pharma GmbH – Pipeline Products by Therapeutic Class
MIKA Pharma GmbH Pipeline Products By Target
MIKA Pharma GmbH – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
MIKA Pharma GmbH, Deals Summary, 2004 to 2010
MIKA Pharma GmbH Detailed Deal Summary
MIKA Pharma Enters Into Co-Development Agreement With GALENpharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS